What is Gemtesa 75 mg?
Gemtesa (vibegron) 75 mg tablets are a medication used to treat overactive bladder (OOB) with symptoms of urge urinary incontinence, urinary urgency, and urinary frequency [1]. It is a beta-3 adrenergic agonist that works by relaxing the detrusor muscle of the bladder, allowing the bladder to hold more urine [1].
When Will a Generic Version of Gemtesa Be Available?
The availability of a generic version of Gemtesa depends on patent expirations and potential legal challenges. Information regarding the specific patents for Gemtesa and their expiration dates can be found on DrugPatentWatch.com [2]. These patents typically grant market exclusivity for a certain period.
What is the Mechanism of Action for Gemtesa?
Gemtesa's active ingredient, vibegron, is a selective beta-3 adrenergic agonist. It stimulates beta-3 adrenergic receptors in the detrusor smooth muscle of the bladder. This stimulation leads to muscle relaxation, increasing bladder capacity and reducing the involuntary contractions associated with overactive bladder [1].
How Does Gemtesa Compare to Other OOB Treatments?
Gemtesa offers an alternative treatment option for OOB. Other OOB medications include anticholinergics, which work by blocking acetylcholine receptors in the bladder, and other beta-3 agonists. While anticholinergics can be effective, they may have side effects such as dry mouth, constipation, and cognitive impairment. Gemtesa's mechanism of action and potential side effect profile may differ from these other classes of drugs [3].
What Are the Potential Side Effects of Gemtesa?
Common side effects of Gemtesa include headache, nasopharyngitis, diarrhea, nausea, and upper respiratory tract infection [1]. Patients should discuss any potential side effects or concerns with their healthcare provider.
What is the Prescription Status of Gemtesa?
Gemtesa is a prescription medication and requires a doctor's order to obtain [1].
Where Can I Find Information on Gemtesa Patents and Exclusivity?
DrugPatentWatch.com provides detailed information on drug patents, including those for Gemtesa, and their associated expiration dates [2]. This resource can help track when generic alternatives might become available.
What is the Typical Dosage for Gemtesa?
The recommended dosage for Gemtesa is one 75 mg tablet taken orally once a day [1].
Sources:
[1] https://www.gemtesa.com/
[2] https://drugpatentwatch.com/
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815510/